- Category Marryalyan
- DATE 22 Feb 2023
Cancer Symptom Trials
February 2023
PaCCSC & CST Annual Research Forum 2023
The PaCCSC & CST Annual Research Forum is our principal annual event. Past forums have supported new study ideas, provided networking opportunities, and forged new collaborations. This year’s theme is Bridging Silos: cross-disciplinary clinical trials
We are focused on developing collaborative cross-disciplinary clinical trials to ensure better quality-of-life outcomes for people living with cancer and life-limiting illnesses.
Join us for the PaCCSC & CST Annual Research Forum in Sydney on 15 and 16 March 2023 to be part of the conversation. Find out more and register: uts.edu.au/paccsc-cst-forum-2023
We are pleased to announce our keynote speakers, Professor Maria Fallon, leader of the Edinburgh Palliative and Supportive Care Group at the University of Edinburgh, and Dr Camilla Zimmermann, Head of the Department of Supportive Care at the Princess Margaret Cancer Centre in Toronto.
Culturally and linguistically diverse (CALD) communities
We are undertaking a program of work to investigate the underrepresentation of culturally and linguistically diverse (CALD) communities in cancer clinical research in Australia.
We want to understand why people with cancer from culturally and linguistically diverse (CALD) communities do and don’t participate in cancer clinical research and whether they are given the opportunity to do so. These insights will help inform the design and implementation of inclusive and culturally appropriate cancer clinical trials.
The first project in this program of work is investigating healthcare professionals’ perspectives on the barriers and enablers of cancer clinical trial participation in the Australian Arabic-speaking community.
Find out more at uts.edu.au/cst/cald
IMPACCT Rapid Program
The IMPACCT Rapid Program is a collaborative international quality improvement program that studies the prospective use of medications and non-pharmacological interventions commonly used in palliative care and cancer symptom management.
Cancer-focused series
- Compression and related physical therapies for lymphoedema - series 25
- Diuretics for cancer-related lymphoedema - series 26
- Dressings for malignant cutaneous wounds - series 38
- Ketamine for cancer-related mucositis pain (paediatric) - series 42
If you are administering or using any of these medications or interventions, you can collect data for these series. To find out more and get involved, go to uts.edu.au/rapid.
Cancer symptom management priority setting - children and young adults
We are conducting a number of surveys to identify the most troubling symptoms or side effects of cancer and its treatments for children and young adults.
We are seeking participants who are:
- Health professionals
- Parents or caregivers
- Young adults living with, or after cancer, between 18 and 24 years of age (inclusive) OR adults who had a cancer diagnosis at or before the age of 24
- Adolescents living with or after cancer, between 11 and 17 years old (inclusive)
- Children living with or after cancer, under 10 years old
We will use the survey results to inform research and clinical trials that investigate ways to improve quality of life for children and young adults living with cancer. This is the first survey of its kind in Australia and New Zealand.
Find out more: uts.edu.au/research/impacct/cancer-symptom-trials/cst-projects
Consumer engagement
Our vision is to see every patient receiving the best care regardless of life circumstances, state of health or place of residence. We will only realise our vision with the invaluable contribution of a diverse and engaged Consumer Advisory Group (CAG) with lived experiences as patients or caregivers.
The IMPACCT Consumer Advisory Group (CAG) has been established to ensure that consumers are actively involved in shaping our research, supporting curricula development and providing general guidance on our strategic direction.
If you, or someone you know, has experience as a patient or caregiver in palliative care, aged care, chronic case or cancer supportive care, we’d love you to consider joining the CAG.
Find out how to become a consumer advisor: www.uts.edu.au/impacct/consumers.
CST clinical trials
Our clinical trials contribute to the knowledge base to inform best practice and ensure improved quality of life for people diagnosed with cancer. We investigate accessible, affordable, and appropriate medicines and therapies for people with cancer, including those living at home.
Go to the CST website to find out more about our clinical trials: www.uts.edu.au/cst
![Blog Details Image](/media/cbtjvvjz/cst_logo-1.png)
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
![](/Frontend/Images/smlogo.png)
COSAoncology 14 days ago
We are pleased that @OSWA_Australia continue to be an Affiliated member organisation with COSA, and look forward to our ongoing collaboration to improve cancer care and control. OSWANZ members can join COSA at a discounted rate. Join or renew here: bit.ly/3s5mOC6
Read More >![](/Frontend/Images/smlogo.png)
COSAoncology 18 days ago
Thank you @RANZCRcollege for maintaining Affiliated membership and continuing to collaborate with COSA to improve cancer care and control. Members of RANZCR can join COSA at a discounted rate. Join or renew here: bit.ly/3s5mOC6
Read More >![](/Frontend/Images/smlogo.png)
COSAoncology 19 days ago
We are pleased that @PathologyRCPA continue to be an Affiliated member organisation with COSA, and look forward to our ongoing collaboration to improve cancer care and control. RCPA members can join COSA at a discounted rate. Join or renew here: bit.ly/3s5mOC6
Read More >![](/Frontend/Images/smlogo.png)
COSAoncology 20 days ago
COSA members on automatic renewal, don't forget to update your billing details before 1 July 2024! Login to the COSA website and go to My Membership, Billing Information: bit.ly/4cI0nc3
Read More >![](/Frontend/Images/smlogo.png)
COSAoncology 21 days ago
Do you prefer to pay membership fees prior to end of financial year? Now is the time to renew your COSA membership: bit.ly/4cI0nc3
Read More >![](/Frontend/Images/smlogo.png)
COSAoncology 21 days ago
We are pleased that @MASC_Trials continue to collaborate with COSA as an Affiliated organisation member. A reminder that MASC Trials members can join COSA at discounted rates! Join or renew here: bit.ly/3s5mOC6
Read More >![](/Frontend/Images/smlogo.png)
COSAoncology 21 days ago
Thank you @CNSA_ORG for maintaining their Affiliated membership and continuing to collaborate with COSA to improve cancer care and control. Members of CNSA can join COSA at a discounted rate. Join or renew here: bit.ly/3s5mOC6
Read More >![](/Frontend/Images/smlogo.png)
COSAoncology one month ago
Thank you to @UTS_CST for continuing to be an Affiliated member organisation with COSA. We look forward to continuing our collaboration to improve cancer care and control. CST members can join COSA at discounted rates! Join or renew here: bit.ly/3s5mOC6
Read More >![](/Frontend/Images/smlogo.png)
COSAoncology one month ago
We are pleased that @POCOG1 continue to collaborate with COSA as an Affiliated organisation member. A reminder that PoCoG members can join COSA at discounted rates! Join or renew here: bit.ly/3s5mOC6
Read More >![](/Frontend/Images/smlogo.png)
COSAoncology one month ago
We are pleased that @ANZCHOG continue to collaborate with COSA as an Affiliated organisation member. A reminder that ANZCHOG members can join COSA at discounted rates! Join or renew here: bit.ly/3s5mOC6
Read More >